Piperazine and (R)-2-(aminomethyl)pyrrolidine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine have recently been shown to be potent and selective adenosine A(2a) receptor antagonists. We have replaced the triazolotriazine core structure with two different heterocyclic cores. One of these, the one deriving from [1,2,4]triazolo[1,5-c]pyrimidine, appears to be particularly effective and selected analogs from this series have been shown to be orally active in a mouse catalepsy model of Parkinson's disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmcl.2004.07.047 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!